2N3A image
Deposition Date 2015-05-26
Release Date 2015-08-19
Last Version Date 2024-05-01
Entry Detail
PDB ID:
2N3A
Keywords:
Title:
Solution structure of LEDGF/p75 IBD in complex with POGZ peptide (1389-1404)
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Conformers Calculated:
100
Conformers Submitted:
29
Selection Criteria:
structures with the least restraint violations
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Pogo transposable element with ZNF domain
Gene (Uniprot):POGZ
Chain IDs:A
Chain Length:16
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:PC4 and SFRS1-interacting protein
Gene (Uniprot):PSIP1
Chain IDs:B
Chain Length:79
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Multiple cellular proteins interact with LEDGF/p75 through a conserved unstructured consensus motif.
Nat Commun 6 7968 7968 (2015)
PMID: 26245978 DOI: 10.1038/ncomms8968

Abstact

Lens epithelium-derived growth factor (LEDGF/p75) is an epigenetic reader and attractive therapeutic target involved in HIV integration and the development of mixed lineage leukaemia (MLL1) fusion-driven leukaemia. Besides HIV integrase and the MLL1-menin complex, LEDGF/p75 interacts with various cellular proteins via its integrase binding domain (IBD). Here we present structural characterization of IBD interactions with transcriptional repressor JPO2 and domesticated transposase PogZ, and show that the PogZ interaction is nearly identical to the interaction of LEDGF/p75 with MLL1. The interaction with the IBD is maintained by an intrinsically disordered IBD-binding motif (IBM) common to all known cellular partners of LEDGF/p75. In addition, based on IBM conservation, we identify and validate IWS1 as a novel LEDGF/p75 interaction partner. Our results also reveal how HIV integrase efficiently displaces cellular binding partners from LEDGF/p75. Finally, the similar binding modes of LEDGF/p75 interaction partners represent a new challenge for the development of selective interaction inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures